Penicillin V-13C6 (potassium)

Penicillin V-13C6 (potassium) is the 13C6 labeled Penicillin V (potassium) . Penicillin V Potassium (Phenoxymethylpenicillin potassium salt) is an orally active antibiotic. Penicillin V Potassium inhibits the growth of Streptococci, C. difficile and S. aureus. Penicillin V Potassium can be used for the research of otitis, sinusitis, pharyngitis and tonsillitis.

Product Specifications

Product Name Alternative

Phenoxymethylpenicillin-13C6 (potassium salt)

UNSPSC

12352005

Hazard Statement

H302, H317, H334

Target

Antibiotic; Bacterial; Isotope-Labeled Compounds

Type

Isotope-Labeled Compounds

Related Pathways

Anti-infection; Others

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/penicillin-v-13c6-potassium.html

Purity

99.8

Solubility

H2O : 6 mg/mL (ultrasonic; warming) |DMSO : 12 mg/mL (ultrasonic; warming)

Smiles

O=C(O[K])[C@@H](C(C)(C)S[C@]1([H])[C@@H]2NC(CO[13C]3=[13CH][13CH]=[13CH][13CH]=[13CH]3)=O)N1C2=O

Molecular Formula

C10 13C6H17KN2O5S

Molecular Weight

394.44

Precautions

H302, H317, H334

References & Citations

[1]Hermansson A, et, al. Prevention of experimental acute otitis media with penicillin V. Acta Otolaryngol. Jan-Feb 1990;109 (1-2) :119-23.|[2]Kamme C, et, al. In vitro effect on group A streptococci of loracarbef versus cefadroxil, cefaclor and penicillin V. Scand J Infect Dis. 1993;25 (1) :37-42.|[3]Norén T, et, al. In vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993-2007 in Sweden. Clin Microbiol Infect. 2010 Aug;16 (8) :1104-10.|[4]Overbosch D, et, al. Comparative pharmacodynamics and clinical pharmacokinetics of phenoxymethylpenicillin and pheneticillin. Br J Clin Pharmacol. 1985 May;19 (5) :657-68.|[5]Sabath LD. Et, al. Phenoxymethylpenicillin (penicillin V) and phenethicillin. Med Clin North Am. 1970 Sep;54 (5) :1101-11.|[6]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.